Pharmaceutical major Lupin has announced the acquisition of Renascience Pharma Limited, a UK-based pharmaceutical company, through its wholly owned subsidiary, Lupin Healthcare (UK) Limited. The transaction, valued at...
Market volatility derails Novartis’ plan to sell stake in its India arm
Swiss pharma giant Novartis AG’s plans to sell a 70.68% equity stake in its listed arm Novartis India has been hobbled as wild swings of the stock market pulls down its valuation. Local drug makers as well as...
Zydus Life extends timeline for Sterling Biotech API business acquisition
Zydus Lifesciences has announced an extension of the closing date for its acquisition of the active pharmaceutical ingredient (API) business of Sterling Biotech Limited (SBL). The transaction, which was initially...
Kedaara, TA Associates vie for minority stake in Sagent Pharma
Homegrown Kedaara Capital and US-based TA Associates are among a clutch of private equity (PE) firms in talks to acquire a significant minority stake in US-based Sagent Pharma, owned by former Gland Pharma promoter Ravi...
Sanofi to acquire Dren Bio’s immunology unit
Sanofi on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201. The French healthcare group will acquire the Dren Bio affiliate Dren...
Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million
Sun Pharmaceutical Industries rose 1.14% to Rs 1,725.55 after its subsidiary, TARO Pharmaceuticals Inc., completed the 100% acquisition of Antibe Therapeutics Inc. of Canada for a total consideration of $4.5 million...
Big pharma mergers unlikely in near future: Dr Reddy’s MD GV Prasad
GV Prasad, co-chairman and managing director, Dr Reddy’s Laboratories, says large mergers and acquisitions in the Indian pharmaceutical market are unlikely in the near future due to various uncertainties. With...
Strides Pharma gains 3% as Singapore arm acquires 100% stake in Amexel Pte
Strides Pharma shares gained 2.8 per cent on BSE, logging an intraday high at Rs 603 per share in Tuesday’s trade. The buying interest sparked after the company arm Strides Pharma Global proposed to acquire 100...
Senores Pharma up 4% as board approves acquisition of 3.73% stake in Havix
Senores Pharma shares rose 3.7 per cent on BSE, logging an intraday high at Rs 572 per share. The stock was in demand after board approved the acquisition of 8,454 shares of Havix which aggregates to 3.73 per cent...
Drugmakers Mallinckrodt, Endo in talks to merge, source says
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on Wednesday. A deal could likely be announced as soon as Thursday, the...
Syngene International shares in focus on acquiring first US biologics facility for $36.5 million
Shares of Syngene International will be in focus on Tuesday after the company announced that it acquired its first biologics facility in the United States from Emergent Manufacturing Operations Baltimore, a unit of...
Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn
Sun Pharmaceuticals announced that it is set to acquire Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million. The transaction is expected to be completed in the second calendar...
